{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:52:31Z","timestamp":1777042351999,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ygyno.2026.02.013","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:54:27Z","timestamp":1776387267000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer"],"prefix":"10.1016","volume":"207","author":[{"given":"Kersten","family":"Rothnie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Tristano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariuxi","family":"Diaz-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Filippova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizelka","family":"David-West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Tymon-Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Frimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung Ming","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidel","family":"Valea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine","family":"Villella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.ygyno.2026.02.013_bb0005","first-page":"661","article-title":"Human papillomavirus\u2013associated cancers \u2014 United States, 2008\u20132012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR"},{"issue":"19","key":"10.1016\/j.ygyno.2026.02.013_bb0010","first-page":"1330","article-title":"Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma","volume":"92","author":"Luan","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.013_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5468\/ogs.2016.59.4.269","article-title":"Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation","volume":"59","author":"Oh","year":"2016","journal-title":"Obstet. Gynecol. Sci."},{"issue":"22","key":"10.1016\/j.ygyno.2026.02.013_bb0020","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/1078-0432.CCR-17-1553","article-title":"Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring","volume":"23","author":"Kang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.013_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cjp2.47","article-title":"Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma","volume":"2","author":"Jeannot","year":"2016","journal-title":"J. Pathol. Clin. Res."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.013_bb0030","article-title":"Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsy","volume":"15","author":"Gupta","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.013_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.23.00954","article-title":"Clinical validation of human papilloma virus circulating tumor DNA for early detection of residual disease after Chemoradiation in cervical Cancer","volume":"42","author":"Han","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.013_bb0040","article-title":"Analytical validation of NavDx, a cfDNA-based Fragmentomic profiling assay for HPV-driven cancers","volume":"13","author":"Gunning","year":"2023","journal-title":"Diagnostics (Basel)."},{"issue":"7","key":"10.1016\/j.ygyno.2026.02.013_bb0045","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1158\/2767-9764.CRC-25-0180","article-title":"Plasma cell-free human papillomavirus DNA and Oral gargle HPV DNA in patients with HPV-related oropharyngeal cancer treated with radiotherapy","volume":"5","author":"Echevarria","year":"2025","journal-title":"Cancer Res. Commun."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.013_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJMc1306040","article-title":"Circulating tumor DNA to monitor metastatic breast cancer","volume":"369","author":"Dawson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"224","key":"10.1016\/j.ygyno.2026.02.013_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2026.02.013_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145754","article-title":"Personalized circulating tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers","volume":"10","author":"Pereira","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ygyno.2026.02.013_bb0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2025.11.005","article-title":"Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: can we further personalize treatment?","volume":"204","author":"Toboni","year":"2026","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.013_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02722-8","article-title":"Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer","volume":"19","author":"Feng","year":"2021","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.013_bb0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/0008-5472.CAN-23-1429","article-title":"Serial circulating tumor DNA analysis with a tumor-na\u00efve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer","volume":"84","author":"Heo","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.013_bb0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1102\/1470-7330.2008.0022","article-title":"The prognostic value of PET and PET\/CT in cervical cancer","volume":"8","author":"Grigsby","year":"2008","journal-title":"Cancer Imag."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.013_bb0085","first-page":"347","article-title":"Detection of early recurrence with 18F-FDG PET in patients with cervical cancer","volume":"44","author":"Ryu","year":"2003","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2026.02.013_bb0090","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1007\/s00259-009-1206-x","article-title":"Efficacy of 18F-FDG PET\/CT in the evaluation of patients with recurrent cervical carcinoma","volume":"36","author":"Mittra","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"11","key":"10.1016\/j.ygyno.2026.02.013_bb0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/RLU.0000000000002252","article-title":"Predictive value of FDG PET\/CT to detect lymph node metastases in cervical Cancer","volume":"43","author":"Brunette","year":"2018","journal-title":"Clin. Nucl. Med."},{"issue":"10","key":"10.1016\/j.ygyno.2026.02.013_bb0100","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal Cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ygyno.2026.02.013_bb0105","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during Chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal Cancer","volume":"25","author":"Chera","year":"2019","journal-title":"Clin. Cancer Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826008073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826008073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:02:58Z","timestamp":1777035778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826008073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"alternative-id":["S0090825826008073"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}